Literature DB >> 29193902

Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies.

Glen Giese1, Ambrose Williams1, Maricel Rodriguez1, Josefine Persson1.   

Abstract

Production of knob and hole dual light chain bispecific antibodies poses several unique challenges for development of a feasible industrial scale manufacturing process. We developed an efficient process for the assembly and purification of knob and hole dual light chain bispecific antibodies. Two distinct half-antibodies targeting two different antigens were expressed separately in Escherichia coli cells and captured independently using Protein A chromatography. When combined, the knob and hole mutations in the CH3 domains promoted heterodimer formation. The hinge region disulfides were reduced and reoxidized to form the disulfide bridge between the two complementary half antibodies. Unreacted half antibodies, noncovalently linked homodimers, covalently linked homodimers, and noncovalently linked heterodimers are impurities closely related to the product of interest and are challenging to remove by standard processes. Characterization of the molecular properties of the half antibodies and high-throughput screening predicted column chromatography performance and allowed for rapid development of downstream purification steps for removal of unique product-related and process-related impurities.
© 2018 American Institute of Chemical Engineers Biotechnol. Prog., 34:397-404, 2018. © 2018 American Institute of Chemical Engineers.

Entities:  

Keywords:  assembly; bispecific antibody; high-throughput screening; knobs into holes; purification

Mesh:

Substances:

Year:  2018        PMID: 29193902     DOI: 10.1002/btpr.2590

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  6 in total

Review 1.  Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas.

Authors:  Ross Salvaris; Jeremy Ong; Gareth P Gregory
Journal:  J Pers Med       Date:  2021-04-29

Review 2.  Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies.

Authors:  Bushra Husain; Diego Ellerman
Journal:  BioDrugs       Date:  2018-10       Impact factor: 5.807

3.  Development of a bioassay to detect T-cell-activating impurities for T-cell-dependent bispecific antibodies.

Authors:  Ho Young Lee; Edward Contreras; Ames C Register; Qiang Wu; Kathleen Abadie; Khristofer Garcia; Pin Yee Wong; Guoying Jiang
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

4.  Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening.

Authors:  Jan P Bogen; Stefania C Carrara; David Fiebig; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

5.  CLEC5a-directed bispecific antibody for effective cellular phagocytosis.

Authors:  Vivekananda Kedage; Diego Ellerman; Mingjian Fei; Wei-Ching Liang; Gu Zhang; Eric Cheng; Juan Zhang; Yongmei Chen; Haochu Huang; Wyne P Lee; Yan Wu; Minhong Yan
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 6.  The Role of Bispecific Antibodies in Non-Hodgkin's Lymphoma: From Structure to Prospective Clinical Use.

Authors:  Rita Tavarozzi; Enrica Manzato
Journal:  Antibodies (Basel)       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.